Larvol Delta - Alzamend-Neuro-Announces-Addition-of-Healthy-Subjects-to-Ongoing-Phase-IIA-Clinical-Trial-for-AL001-in-Alzheimers-Subjects

LiProSal (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20221005005399/en/Alzamend-Neuro-Announces-Addition-of-Healthy-Subjects-to-Ongoing-Phase-IIA-Clinical-Trial-for-AL001-in-Alzheimer%E2%80%99s-Subjects

Oct 5, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next